Nine months after a historic high-level UN meeting where countries pledged to end the global tuberculosis epidemic by 2030, a chronic lack of R&D financing jeopardises that ambitious goal, said expert panelists at a briefing on the TB R&D landscape last week in Geneva, hosted by South Africa’s Permanent Mission to the UN. While there […] Continue reading ->
In the lead-up to the United Nations High-Level Meeting on Universal Health Coverage (UHC) in September, the latest draft of a planned political declaration calls on member states to increase transparency of the cost of research and development (R&D) – in addition to drug prices – but falls short in the area of R&D incentive […] Continue reading ->
Following the adoption of the World Health Assembly resolution on the transparency of medicines markets last month, a new civil society group has formed in France to monitor the French government’s implementation of the resolution. L’Observatoire Transparence Médicaments (Drug Transparency Observatory), was launched today in a statement calling on the French government and all countries […] Continue reading ->
Extending the reach of primary health care systems to provide malaria services to those in the most hard-to-reach places has become part and parcel to the global malaria response, and according to experts, is paving the way for the expansion of other essential health services – and moving the world closer towards realising universal health […] Continue reading ->
After applauding the United States Congress for passing a bill that aims to strengthen preparedness against global disease threats, an R&D advocacy group is now calling on Congressional leaders to ensure there is actually money allocated to fund an expanded set of activities. Image Credits: PATH/Eric Becker. Continue reading ->
This week’s Women Deliver 2019 Conference on gender equality and the health, rights, and well-being of girls and women, has captured the world’s attention, drawing three African heads of state as well as Canadian Prime Minister Justin Trudeau; international NGOs; and directors of UN Agencies, including a host of high-level WHO officials, as among the […] Continue reading ->
(Human Rights Watch) – The World Health Organization (WHO) approved a major change to its global manual of diagnoses on May 25, 2019, that will greatly benefit transgender people around the world, Human Rights Watch said today. The World Health Assembly, the WHO governing body that represents 194 member states, voted for new diagnostic guidelines […] Continue reading ->
The latest working draft World Health Assembly resolution calling for game-changing public disclosure of the prices paid for medicines, vaccines and other health products by countries and health systems shows a broad coalition of countries from Europe, Latin America, Africa and Asia forming around the compromise draft. The draft, obtained Sunday by Health Policy Watch, […] Continue reading ->
After a grueling 34 hours of nearly non-stop negotiations, World Health Assembly delegates appeared to be close to a final agreement Saturday evening on a resolution supporting more systematic disclosure of prices for medicines purchased and sold on national and global markets; a “drafting group” is expected to reconvene Monday morning to put the finishing […] Continue reading ->
The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading ->